RO7763505 / Roche - LARVOL DELTA

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease (clinicaltrials.gov) - P1 | N=196 | Active, not recruiting | Sponsor: Hoffmann-La Roche | Recruiting ➔ Active, not recruiting | Trial completion date: Feb 2028 ➔ Oct 2026 | Trial primary completion date: Feb 2028 ➔ Oct 2026

Enrollment closed • Trial completion date • Trial primary completion date • Cardiovascular • Coronary Artery Disease • Heart Failure

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease (clinicaltrials.gov) - P1 | N=196 | Recruiting | Sponsor: Hoffmann-La Roche

Trial initiation date • Cardiovascular • Coronary Artery Disease • Heart Failure

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease (clinicaltrials.gov) - P1 | N=196 | Recruiting | Sponsor: Hoffmann-La Roche | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Coronary Artery Disease • Heart Failure • IL1B

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease (clinicaltrials.gov) - P1 | N=196 | Recruiting | Sponsor: Hoffmann-La Roche

New P1 trial • Cardiovascular • Coronary Artery Disease • Heart Failure